View in EDS

A pooled analysis of phase 2 clinical trials in advanced chordoma.

Saved in:
Bibliographic Details
Title: A pooled analysis of phase 2 clinical trials in advanced chordoma.
Authors: Cote GM; Mass General Brigham Cancer Institute, Boston MA, United States. Electronic address: Gcote@mgh.harvard.edu., Elliott CF; Berry Consultants, Austin, TX, United States., Lipplaa A; Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands., Gelderblom H; Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands., Blay JY; Centre Léon Bérard, Lyon, Rhone-Alpes, France., Le Cesne A; International Department, Gustave Roussy Institute, Villejuif, Ile-de-France, France., Duffaud F; APHM Hôpital La Timone and Aix Marseille Universite (AMU), Marseille, France., Kesari S; Asthra Health and Lundquist Institute, Santa Monica, CA, United States., George S; Department of Medical Oncology, Sarcoma Center, Dana-Farber Cancer Institute, Boston, MA, United States., Somaiah N; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, University of Texas, MD Anderson Cancer Center, Houston, TX, United States., Conley AP; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, University of Texas, MD Anderson Cancer Center, Houston, TX, United States., Teleanu MV; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany., Fröhling S; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany; Division of Translational Precision Medicine, Institute of Human Genetics, Heidelberg University, Heidelberg, Germany., Schlenk RF; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany; Department of Medical Oncology and Department of Hematology, Oncology, and Rheumatology, University of Heidelberg, Heidelberg, Baden-Württemberg, Germany., Bompas E; Institut de Cancerologie de l'Ouest, Saint Herblain, Pays la Loire, France., Schuetze SM; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, United States., Chugh R; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, United States., Choy E; Mass General Brigham Cancer Institute, Boston MA, United States., Chemudupati T; Chordoma Foundation, Durham, NC, United States., Lozinsky S; Chordoma Foundation, Durham, NC, United States., Freed DM; Chordoma Foundation, Durham, NC, United States., Sommer J; Chordoma Foundation, Durham, NC, United States., Wendelberger B; Berry Consultants, Austin, TX, United States., Stacchiotti S; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2026 Jun 10; Vol. 244, pp. 116875. Date of Electronic Publication: 2026 Jun 10.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42302352
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A pooled analysis of phase 2 clinical trials in advanced chordoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Cote+GM%22">Cote GM</searchLink>; Mass General Brigham Cancer Institute, Boston MA, United States. Electronic address: Gcote@mgh.harvard.edu.<br /><searchLink fieldCode="AU" term="%22Elliott+CF%22">Elliott CF</searchLink>; Berry Consultants, Austin, TX, United States.<br /><searchLink fieldCode="AU" term="%22Lipplaa+A%22">Lipplaa A</searchLink>; Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands.<br /><searchLink fieldCode="AU" term="%22Gelderblom+H%22">Gelderblom H</searchLink>; Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands.<br /><searchLink fieldCode="AU" term="%22Blay+JY%22">Blay JY</searchLink>; Centre Léon Bérard, Lyon, Rhone-Alpes, France.<br /><searchLink fieldCode="AU" term="%22Le+Cesne+A%22">Le Cesne A</searchLink>; International Department, Gustave Roussy Institute, Villejuif, Ile-de-France, France.<br /><searchLink fieldCode="AU" term="%22Duffaud+F%22">Duffaud F</searchLink>; APHM Hôpital La Timone and Aix Marseille Universite (AMU), Marseille, France.<br /><searchLink fieldCode="AU" term="%22Kesari+S%22">Kesari S</searchLink>; Asthra Health and Lundquist Institute, Santa Monica, CA, United States.<br /><searchLink fieldCode="AU" term="%22George+S%22">George S</searchLink>; Department of Medical Oncology, Sarcoma Center, Dana-Farber Cancer Institute, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Somaiah+N%22">Somaiah N</searchLink>; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, University of Texas, MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Conley+AP%22">Conley AP</searchLink>; Department of Sarcoma Medical Oncology, Division of Cancer Medicine, University of Texas, MD Anderson Cancer Center, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Teleanu+MV%22">Teleanu MV</searchLink>; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Fröhling+S%22">Fröhling S</searchLink>; Division of Translational Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany; German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany; Division of Translational Precision Medicine, Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Schlenk+RF%22">Schlenk RF</searchLink>; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany; Department of Medical Oncology and Department of Hematology, Oncology, and Rheumatology, University of Heidelberg, Heidelberg, Baden-Württemberg, Germany.<br /><searchLink fieldCode="AU" term="%22Bompas+E%22">Bompas E</searchLink>; Institut de Cancerologie de l'Ouest, Saint Herblain, Pays la Loire, France.<br /><searchLink fieldCode="AU" term="%22Schuetze+SM%22">Schuetze SM</searchLink>; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, United States.<br /><searchLink fieldCode="AU" term="%22Chugh+R%22">Chugh R</searchLink>; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI, United States.<br /><searchLink fieldCode="AU" term="%22Choy+E%22">Choy E</searchLink>; Mass General Brigham Cancer Institute, Boston MA, United States.<br /><searchLink fieldCode="AU" term="%22Chemudupati+T%22">Chemudupati T</searchLink>; Chordoma Foundation, Durham, NC, United States.<br /><searchLink fieldCode="AU" term="%22Lozinsky+S%22">Lozinsky S</searchLink>; Chordoma Foundation, Durham, NC, United States.<br /><searchLink fieldCode="AU" term="%22Freed+DM%22">Freed DM</searchLink>; Chordoma Foundation, Durham, NC, United States.<br /><searchLink fieldCode="AU" term="%22Sommer+J%22">Sommer J</searchLink>; Chordoma Foundation, Durham, NC, United States.<br /><searchLink fieldCode="AU" term="%22Wendelberger+B%22">Wendelberger B</searchLink>; Berry Consultants, Austin, TX, United States.<br /><searchLink fieldCode="AU" term="%22Stacchiotti+S%22">Stacchiotti S</searchLink>; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229005373%22">European journal of cancer (Oxford, England : 1990)</searchLink> [Eur J Cancer] 2026 Jun 10; Vol. 244, pp. 116875. <i>Date of Electronic Publication: </i>2026 Jun 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ltd%22">Elsevier Science Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9005373 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0852 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209598049%22">09598049 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42302352
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ejca.2026.116875
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 116875
    Titles:
      – TitleFull: A pooled analysis of phase 2 clinical trials in advanced chordoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cote GM
      – PersonEntity:
          Name:
            NameFull: Elliott CF
      – PersonEntity:
          Name:
            NameFull: Lipplaa A
      – PersonEntity:
          Name:
            NameFull: Gelderblom H
      – PersonEntity:
          Name:
            NameFull: Blay JY
      – PersonEntity:
          Name:
            NameFull: Le Cesne A
      – PersonEntity:
          Name:
            NameFull: Duffaud F
      – PersonEntity:
          Name:
            NameFull: Kesari S
      – PersonEntity:
          Name:
            NameFull: George S
      – PersonEntity:
          Name:
            NameFull: Somaiah N
      – PersonEntity:
          Name:
            NameFull: Conley AP
      – PersonEntity:
          Name:
            NameFull: Teleanu MV
      – PersonEntity:
          Name:
            NameFull: Fröhling S
      – PersonEntity:
          Name:
            NameFull: Schlenk RF
      – PersonEntity:
          Name:
            NameFull: Bompas E
      – PersonEntity:
          Name:
            NameFull: Schuetze SM
      – PersonEntity:
          Name:
            NameFull: Chugh R
      – PersonEntity:
          Name:
            NameFull: Choy E
      – PersonEntity:
          Name:
            NameFull: Chemudupati T
      – PersonEntity:
          Name:
            NameFull: Lozinsky S
      – PersonEntity:
          Name:
            NameFull: Freed DM
      – PersonEntity:
          Name:
            NameFull: Sommer J
      – PersonEntity:
          Name:
            NameFull: Wendelberger B
      – PersonEntity:
          Name:
            NameFull: Stacchiotti S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 06
              Text: 2026 Jun 10
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1879-0852
          Numbering:
            – Type: volume
              Value: 244
          Titles:
            – TitleFull: European journal of cancer (Oxford, England : 1990)
              Type: main
ResultId 1